Q2 2025 Earnings Call Transcript August 14, 2025Brainstorm Cell Therapeutics Inc. beats earnings expectations.

The United States has designated the Balochistan Liberation Army (BLA) as a terrorist organisation — a move welcomed by ...

Shares of Precigen ( NASDAQ: PGEN) added ~94% in the premarket on Friday after the U.S. Food and Drug Administration (FDA) ...

The Baloch Liberation Army (BLA) has rejected the United States' decision to classify its unit, the Majeed Brigade, as a ...

The Government of Pakistan has blocked over 500 social media accounts linked to banned militant groups after reporting over 850 accounts on different platforms in a nationwide crackdown.The accounts, ...

The Baloch Liberation Army (BLA) has rejected the United States' decision to classify its unit, the Majeed Brigade, as a ...

Revenue-- Revenue net of returns was $86,000, reflecting intentional reductions in ClearUp marketing and unit sales. Operating expenses-- Operating expenses were $2.0 million, up from $1.3 million in ...

WALTHAM, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced financial results for the quarter ended June 30, 2025, and provided recent business highlights.

Presented positive results from the phase 3 randomized, placebo-controlled clinical trial of CAN-2409 (aglatimagene besadenovec) in localized prostate cancer, during an oral presentation at the 2025 ...

GAAP EPS loss of $0.41 in Q2 2025 beat analyst expectations for a larger loss of $0.48 per share. R&D expenses (GAAP) rose 19% to $23.4 million in Q2 2025 compared to Q2 2024, primarily due to higher ...